Back to PCVX
T. Rowe Price Investment Management, Inc. → PCVX
T. Rowe Price Investment Management, Inc. PCVX Position History
Vaxcyte, Inc. • Healthcare
Quarters held
5
Latest value
$813.7M
Q3 2026
Peak value
$813.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $308.3M |
| Q4 2025 | $521.2M |
| Q1 2026 | $704.6M |
| Q2 2026 | $709.6M |
| Q3 2026 | $813.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $813.7M | 14.30M | — | — |
| Q2 2026 | $709.6M | 12.21M | — | — |
| Q1 2026 | $704.6M | 12.13M | — | — |
| Q4 2025 | $521.2M | 11.30M | — | — |
| Q4 2025 | $308.3M | 6.68M | — | — |
Other funds holding PCVX
$1.4B
$963.5M
$936.4M
$936.4M
$888.6M
$818.9M
$796.5M